Corium (CORI) Investors: H.C. Wainwright Reaffirms Buy Rating, Sees $14.0/Share; Last Week Fenner PLC (LON:FENR) Coverage

Among 15 analysts covering Fenner PLC (LON:FENR), 5 have Buy rating, 6 Sell and 4 Hold. Therefore 33% are positive. Fenner PLC had 140 analyst reports since July 22, 2015 according to SRatingsIntel. The stock has “Hold” rating by Numis Securities on Friday, September 4. The company was maintained on Friday, September 18 by Panmure Gordon. The firm has “Add” rating by Numis Securities given on Friday, July 7. The rating was maintained by Peel Hunt on Friday, September 15 with “Buy”. Citigroup maintained the shares of FENR in report on Thursday, April 20 with “Buy” rating. Jefferies maintained it with “Buy” rating and GBX 205 target in Friday, September 9 report. Jefferies maintained it with “Buy” rating and GBX 145 target in Wednesday, January 13 report. FinnCap maintained the shares of FENR in report on Friday, September 11 with “Hold” rating. The company was maintained on Friday, December 18 by Panmure Gordon. The stock of Fenner PLC (LON:FENR) earned “Hold” rating by Liberum Capital on Tuesday, September 8. See Fenner PLC (LON:FENR) latest ratings:

05/12/2017 Broker: Numis Securities Rating: Hold Old Target: GBX 400.00 New Target: GBX 400.00 Maintain
20/11/2017 Broker: Citigroup Rating: Buy Old Target: GBX 400.00 New Target: GBX 425.00 Maintain
16/11/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 345.00 New Target: GBX 380.00 Maintain
15/11/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 425.00 New Target: GBX 425.00 Maintain
15/11/2017 Broker: N+1 Singer Rating: Buy Maintain
03/11/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 425.00 New Target: GBX 425.00 Maintain
31/10/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 425.00 New Target: GBX 425.00 Maintain
27/10/2017 Broker: FinnCap Rating: Buy Old Target: GBX 385.00 New Target: GBX 385.00 Maintain
18/10/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 380.00 New Target: GBX 425.00 Maintain
15/09/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 380.00 New Target: GBX 380.00 Maintain

Among 7 analysts covering Corium International (NASDAQ:CORI), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Corium International has $20 highest and $800 lowest target. $14.14’s average target is 42.11% above currents $9.95 stock price. Corium International had 22 analyst reports since August 25, 2015 according to SRatingsIntel. Needham maintained Corium International, Inc. (NASDAQ:CORI) rating on Monday, November 20. Needham has “Buy” rating and $16.0 target. On Friday, November 17 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating by Zacks given on Wednesday, September 2. Needham maintained it with “Buy” rating and $13.0 target in Friday, September 15 report. The rating was maintained by Jefferies with “Buy” on Monday, August 7. The stock has “Buy” rating by Needham on Monday, November 16. The stock has “Buy” rating by Cantor Fitzgerald on Friday, December 22. Jefferies maintained Corium International, Inc. (NASDAQ:CORI) on Friday, October 27 with “Buy” rating. Zacks downgraded Corium International, Inc. (NASDAQ:CORI) on Tuesday, August 25 to “Buy” rating. The rating was maintained by Jefferies on Friday, May 26 with “Buy”.

The stock decreased 3.49% or $0.36 during the last trading session, reaching $9.95. About 264,504 shares traded or 47.56% up from the average. Corium International, Inc. (NASDAQ:CORI) has risen 84.14% since December 27, 2016 and is uptrending. It has outperformed by 67.44% the S&P500.

Investors sentiment decreased to 3.67 in Q3 2017. Its down 4.73, from 8.4 in 2017Q2. It turned negative, as 2 investors sold Corium International, Inc. shares while 7 reduced holdings. 11 funds opened positions while 22 raised stakes. 62.14 million shares or 0.80% more from 61.65 million shares in 2017Q2 were reported. The Georgia-based Voya Invest Management Limited Co has invested 0% in Corium International, Inc. (NASDAQ:CORI). Bridgeway Mgmt holds 189,600 shares or 0.02% of its portfolio. Tower Capital Limited Liability (Trc) stated it has 2,409 shares or 0% of all its holdings. The New York-based Goldman Sachs has invested 0% in Corium International, Inc. (NASDAQ:CORI). Perceptive Advisors Limited Liability accumulated 5.85 million shares. Opaleye Mgmt reported 920,000 shares. Pennsylvania-based Vanguard has invested 0% in Corium International, Inc. (NASDAQ:CORI). Needham Inv Management Lc holds 1.54% or 549,524 shares in its portfolio. Iguana Health reported 125,000 shares or 0.77% of all its holdings. The New York-based Metropolitan Life Insur Ny has invested 0% in Corium International, Inc. (NASDAQ:CORI). Schwab Charles Invest Mngmt Incorporated reported 0% stake. Blackrock Incorporated invested 0% in Corium International, Inc. (NASDAQ:CORI). Victory Cap Mgmt accumulated 0% or 4,686 shares. Broadfin Capital Ltd Com holds 7.27% of its portfolio in Corium International, Inc. (NASDAQ:CORI) for 4.44M shares. California State Teachers Retirement invested in 0% or 39,500 shares.

Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. The company has market cap of $358.25 million. It offers Clonidine Transdermal Delivery System , a treatment for hypertension; Fentanyl TDS, a treatment for the management of chronic pain, including cancer-related pain; and Crest Whitestrips for teeth whitening. It currently has negative earnings. The companyÂ’s products under pipeline comprise Twirla, a combination hormonal contraceptive patch, which has completed Phase III clinical trial to deliver ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system that has completed Phase 1 and Phase II a clinical trial for the treatment of severe osteoporosis; and Donepezil and Memantine transdermal systems, which completed Phase I clinical trial for the treatment of Alzheimer's disease.

Analysts await Corium International, Inc. (NASDAQ:CORI) to report earnings on February, 12. They expect $-0.42 earnings per share, up 8.70% or $0.04 from last year’s $-0.46 per share. After $-0.36 actual earnings per share reported by Corium International, Inc. for the previous quarter, Wall Street now forecasts 16.67% negative EPS growth.